AIDS survival: first drop in total deaths in U.S.; larger drop in France. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply. NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


AIDS survival: first drop in total deaths in U.S.; larger drop in France. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

AIDS Treat News. 1997 Mar 7;(No 266):1, 6-7. Unique Identifier : AIDSLINE AIDS/97702534
James JS

Abstract: In February 1997, the U.S. Centers for Disease Control and Prevention (CDC) reported a 12 percent decline in AIDS deaths over a 1-year period, the first drop in total deaths from AIDS in the United States. The decline was greatest in the West and Northeast, followed by the Midwest and South. By ethnicity, the drop was greatest among non-Hispanic whites and American Indians/Alaskan Natives. Deaths increased in women and persons infected heterosexually, but declined for men and other risk groups, such as men who have sex with men and injection drug users. France also reported a 25 percent reduction in AIDS deaths from 1995 to 1996, as well as a 21 percent decrease in diagnosed AIDS cases from the first to second half of 1996.
Keywords: Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY/*MORTALITY Female France/EPIDEMIOLOGY Human Male Risk Factors Sex Behavior Substance Abuse, Intravenous United States/EPIDEMIOLOGY NEWSLETTER ARTICLEKWDacquiredimmunodeficiencysyndrome/epidemiology/KWDmortalityfemalefrance/epidemiologyhumanmaleriskfactorssexbehaviorsubstanceabuse,intravenousunitedstates/epidemiologynewsletterarticle
970830
M9781217

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .